Related Experiment Videos
Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy?
C Wadström1, J Zedenius, A Guinea
1Karolinska Institute, Danderyd Hospital, Sweden.
The Australian and New Zealand Journal of Surgery
|February 5, 1999
Summary
Hemithyroidectomy is adequate for single thyroid nodules later found to be multinodular goiters. Clinical recurrence is low (12%), and thyroxine therapy does not prevent recurrence in these thyroid surgery patients.
Area of Science:
- Endocrinology
- Surgical Oncology
- Thyroid Disease Management
Background:
- Hemithyroidectomy is standard for single thyroid nodules requiring surgery.
- Unsuspected multinodular change post-surgery carries recurrence risk in the remaining lobe.
- Assessing outcomes for hemithyroidectomy in cases of initially single nodules with later multinodular goiter findings is crucial.
Purpose of the Study:
- To evaluate the clinical outcome of patients undergoing hemithyroidectomy for a single thyroid nodule.
- To determine the recurrence rate and need for further surgery when the nodule is part of a multinodular goiter.
- To assess the efficacy of thyroxine treatment in preventing recurrence.
Main Methods:
- Retrospective survey of patients from a thyroid surgery database.
- Inclusion criteria: hemithyroidectomy for a clinical single nodule with confirmed multinodular change on histopathology.
- Outcome measures: clinical recurrence rate, subsequent surgery frequency, and thyroxine treatment effect.
Main Results:
- A clinical recurrence rate of 12% was observed in 229 studied patients.
- Fourteen out of 28 patients with recurrence required additional thyroid surgery.
- Thyroxine therapy demonstrated no significant impact on recurrence rates.
Conclusions:
- Hemithyroidectomy is an adequate surgical approach for clinically benign single thyroid nodules later identified as part of a multinodular goiter.
- Patients can be reassured regarding a low probability of clinical recurrence after this procedure.
- Thyroxine replacement therapy does not appear to prevent recurrence in this patient cohort.